Clinical Trials Browser

Phase 2 × Esophageal Neoplasms × saracatinib × Clear all

NCT00607594 2018-08-23

Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer

Phase 2 Completed

21 enrolled 11 charts

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms